Han Biomedical (ROCO:6999) EPS (Basic): NT$1.03 (TTM As of Dec. 2025)


ROCO:6999 Han Biomedical Inc ROCO:6999
26 GF Score
Price NT$30.50
! 1 Warning Sign
View Full Analysis

What is Han Biomedical EPS (Basic)?

Han Biomedical ROCO:6999 +3.39% 26 EPS (Basic) is NT$1.03 as of Dec. 2025. GuruFocus rates ROCO:6999 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Han Biomedical's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was NT$0.58. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.03.

Han Biomedical's EPS (Diluted) for the six months ended in Dec. 2025 was NT$0.57. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.02.

Han Biomedical's EPS without NRI for the six months ended in Dec. 2025 was NT$0.57. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 1.02.

During the past 12 months, Han Biomedical's average EPS without NRIGrowth Rate was -15.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Han Biomedical's highest 3-Year average EPS without NRI Growth Rate was 22.20% per year. The lowest was 4.40% per year. And the median was 13.30% per year.

Han Biomedical  (ROCO:6999) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Han Biomedical EPS (Basic) Related Terms

Han Biomedical EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Han Biomedical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Han Biomedical EPS (Basic) Chart

Han Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
0.66 0.91 1.03 1.20 1.03

Han Biomedical Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial 0.67 0.49 0.71 0.45 0.58
ROCO:6999
26GF Score
Han Biomedical Inc ROCO:6999
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Han Biomedical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Han Biomedical's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(22.567-0)/22.015
=1.03

Han Biomedical's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(12.655-0)/22.014
=0.57

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NT$1.03 mean?
Han Biomedical (ROCO:6999) has a EPS (Basic) of NT$1.03 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Han Biomedical and its competitors.
Is Han Biomedical's EPS (Basic) too high?
Han Biomedical's current EPS (Basic) is NT$1.03. Overall, Han Biomedical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's EPS (Basic) compare to VRTX and REGN?
Han Biomedical's EPS (Basic) of NT$1.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Han Biomedical and its competitors. Han Biomedical's current EPS (Basic) is NT$1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current EPS (Basic) of NT$1.03. The current EPS (Basic) is NT$1.03. Han Biomedical's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current EPS (Basic) is NT$1.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Han Biomedical Business Description

Address Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
26GF Score

Get the complete analysis for ROCO:6999

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.50
Price